Literature DB >> 16004964

Ubiquitination of the common cytokine receptor gammac and regulation of expression by an ubiquitination/deubiquitination machinery.

Franck Gesbert1, Valérie Malardé, Alice Dautry-Varsat.   

Abstract

The common cytokine receptor gamma(c) is shared by the interleukin-2, -4, -7, -9, -15, and -21 receptors, and is essential for lymphocyte proliferation and survival. The regulation of gamma(c) receptor expression level is therefore critical for the ability of cells to respond to these cytokines. We previously reported that gamma(c) is efficiently constitutively internalized and addressed towards a degradation endocytic compartment. We show that gamma(c) is ubiquitinated and also associated to ubiquitinated proteins. We report that the ubiquitin-ligase c-Cbl induces gamma(c) down-regulation. In addition, the ubiquitin-hydrolase, DUB-2, counteracts the effect of c-Cbl on gamma(c) expression. We show that an increase in DUB-2 expression correlates with an increased gamma(c) half-life, resulting in the up-regulation of the receptor. Altogether, we show that gamma(c) is the target of an ubiquitination mechanism and its expression level can be regulated through the activities of a couple of ubiquitin-ligase/ubiquitin-hydrolase enzymes, namely c-Cbl/DUB-2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004964     DOI: 10.1016/j.bbrc.2005.06.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation.

Authors:  Jing Zhao; Jianxin Wei; Rachel K Mialki; Daniel F Mallampalli; Bill B Chen; Tiffany Coon; Chunbin Zou; Rama K Mallampalli; Yutong Zhao
Journal:  Nat Immunol       Date:  2012-06-03       Impact factor: 25.606

2.  IL-7 induces clathrin-mediated endocytosis of CD127 and subsequent degradation by the proteasome in primary human CD8 T cells.

Authors:  Elliott M Faller; Feras M Ghazawi; Marko Cavar; Paul A MacPherson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

Review 3.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

4.  The deubiquitinating enzyme USP10 regulates the endocytic recycling of CFTR in airway epithelial cells.

Authors:  Jennifer M Bomberger; Roxanna L Barnaby; Bruce A Stanton
Journal:  Channels (Austin)       Date:  2010 May-Jun       Impact factor: 2.581

5.  Regulation of IL-4 receptor signaling by STUB1 in lung inflammation.

Authors:  Qin Wei; Youbao Sha; Abhisek Bhattacharya; Elmoataz Abdel Fattah; Diana Bonilla; Soma S S K Jyothula; Lavannya Pandit; Gurjit K Khurana Hershey; N Tony Eissa
Journal:  Am J Respir Crit Care Med       Date:  2014-01-01       Impact factor: 21.405

6.  Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules.

Authors:  Lidia M Duncan; Siân Piper; Roger B Dodd; Mark K Saville; Chris M Sanderson; J Paul Luzio; Paul J Lehner
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

7.  The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells.

Authors:  Jennifer M Bomberger; Roxanna L Barnaby; Bruce A Stanton
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

Review 8.  Deubiquitylation and regulation of the immune response.

Authors:  Shao-Cong Sun
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

Review 9.  Deubiquitylating enzymes and disease.

Authors:  Shweta Singhal; Matthew C Taylor; Rohan T Baker
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

Review 10.  Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia.

Authors:  Laura Patrussi; Nagaja Capitani; Cosima T Baldari
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.